Ensoma

Ensoma is a team of fearless innovators committed to transforming the future of medicine by making life-changing genetic therapies more accessible. We’re driven by a “What if we…” mindset, tackling the toughest questions to create breakthrough, one-time genetic medicines through cutting-edge in vivo cellular engineering. Using our pioneering base editing and high-efficiency gene integration platform, we directly engineer hematopoietic stem cells (HSCs) from within, creating treatments that could rewrite the outcomes for genetic, immune and oncological diseases like CGD, sickle cell disease and cancer.

Every success here is shared. Our culture thrives on trust, collaboration and a shared vision to drive innovation while elevating each other’s impact. We empower one another to bring bold ideas to life, tackle challenges together, and create a workplace where learning and support fuel our growth. Ensoma’s team includes top-tier talent backed by passionate investors, all committed to a better future for patients and each other. We offer a competitive benefits package that prioritizes wellness, growth and balance, and we invite mission-driven innovators to join us on this journey.

Ensoma is based in Boston. Learn more at ensoma.com. #InsideEnsoma

AWARDS
  • NextGen Class of 2022
  • 2024 Best Places to Work
  • 2025 BPTW Badge - RBG.png
451 D Street Unit #711
Boston, MA 02210 US
NEWS
BioSpace has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
JOBS
IN THE PRESS